965 related articles for article (PubMed ID: 16910353)
21. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
Goldstein NS; Kestin LL; Vicini FA
Cancer; 2001 Aug; 92(4):738-47. PubMed ID: 11550142
[TBL] [Abstract][Full Text] [Related]
23. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
Calabrese L
Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
[TBL] [Abstract][Full Text] [Related]
24. Recent trends in the management of breast cancer. 1. Carcinoma in situ of the breast.
Donegan WL
Can J Surg; 1992 Aug; 35(4):361-5. PubMed ID: 1323379
[TBL] [Abstract][Full Text] [Related]
25. Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
Schouten van der Velden AP; van Vugt R; Van Dijck JA; Leer JW; Wobbes T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):703-10. PubMed ID: 17544591
[TBL] [Abstract][Full Text] [Related]
26. Lobular carcinoma in situ on core biopsy-what is the clinical significance?
O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R
Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699
[TBL] [Abstract][Full Text] [Related]
27. Ductal carcinoma in situ of the breast: our experience.
Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N
G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465
[TBL] [Abstract][Full Text] [Related]
28. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
29. Ductal carcinoma in situ of the breast. Long-term follow-up of health-related quality of life, emotional reactions and body image.
Sackey H; Sandelin K; Frisell J; Wickman M; Brandberg Y
Eur J Surg Oncol; 2010 Aug; 36(8):756-62. PubMed ID: 20598492
[TBL] [Abstract][Full Text] [Related]
30. Incidental finding of mammary carcinoma in lumpectomy specimens.
Tang P; Hajdu SI; Conte CC; Filardi DA
Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
[TBL] [Abstract][Full Text] [Related]
31. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
Sacchini V; Pinotti JA; Barros AC; Luini A; Pluchinotta A; Pinotti M; Boratto MG; Ricci MD; Ruiz CA; Nisida AC; Veronesi P; Petit J; Arnone P; Bassi F; Disa JJ; Garcia-Etienne CA; Borgen PI
J Am Coll Surg; 2006 Nov; 203(5):704-14. PubMed ID: 17084333
[TBL] [Abstract][Full Text] [Related]
32. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
[TBL] [Abstract][Full Text] [Related]
33. Therapy of in situ cancer.
Recht A; Connolly JL; Schnitt SJ; Harris JR
Hematol Oncol Clin North Am; 1989 Dec; 3(4):691-708. PubMed ID: 2558105
[TBL] [Abstract][Full Text] [Related]
34. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
Mokbel K
Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
[TBL] [Abstract][Full Text] [Related]
35. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
36. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
37. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
[TBL] [Abstract][Full Text] [Related]
38. [Ductal carcinoma in situ of the breast].
Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; Gili S; Lo Schiavo F
G Chir; 2006; 27(1-2):40-4. PubMed ID: 16608632
[TBL] [Abstract][Full Text] [Related]
39. The dilemma of DCIS.
Morrow M; O'Sullivan MJ
Breast; 2007 Dec; 16 Suppl 2():S59-62. PubMed ID: 17714949
[TBL] [Abstract][Full Text] [Related]
40. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
